Article info

Findings that shed new light on the possible pathogenesis of a disease or an adverse effect
Deterioration of the liver biochemistry due to reactivation of chronic hepatitis B during etanercept treatment for rheumatoid arthritis
  1. Chang-Youh Tsai, cytsai{at}vghtpe.gov.tw
View Full Text

Citation

Kuo S, Lee H, Chen W, et al
Deterioration of the liver biochemistry due to reactivation of chronic hepatitis B during etanercept treatment for rheumatoid arthritis

Publication history

  • First published March 17, 2009.
Online issue publication 
March 17, 2009

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.